Thursday, May 19, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Medical Countermeasures

Watch: BARDA Director Talks About Emergency Use Authorization of Third COVID-19 Vaccine

by Global Biodefense Staff
March 1, 2021

Gary Disbrow, Ph.D., BARDA Director at HHS/ASPR, explains the public-private collaboration and platform technologies brought to bear for COVID-19 vaccines.

Highlighted comments from the transcript:

The FDA’s emergency use authorization of Janssen’s COVID-19 vaccine – part of Johnson & Johnson – is exciting news on many fronts.

A single dose vaccine stored at refrigerated temperatures, that prevents hospitalizations and deaths from COVID-19, has the potential to change the trajectory of the pandemic in the U.S. and globally.

BARDA has partnered with Janssen since 2015, working together on influenza and an Ebola vaccine.

In February of 2020, BARDA and Janssen partnered again to develop a COVID-19 vaccine utilizing the same technology behind their Ebola vaccine that was licensed in the European Union.

Janssen has leveraged BARDA’s Centers for Innovation in Advanced Development and Manufacturing and our fill-finish manufacturing network – resources we created after the 2009 influenza pandemic – to manufacture this vaccine in the United States.

Through the development of this vaccine, we are seeing the results of years of work on platform technologies and public-private partnerships coming to fruition.

Tags: COVID CountermeasuresCOVID-19Editor PickEUASARS-CoV-2Vaccines

Related Posts

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs
Medical Countermeasures

New Research on Building Blocks of Poxviruses Could Lead to Antiviral Drugs

April 10, 2022
Yersinia pestis
Funding News

NIH Awards $3M Grant to Albany Med for Plague Vaccine Development

April 8, 2022
Troubling Trends in Physician Vaccine Confidence in the United States
Medical Countermeasures

Troubling Trends in Physician Vaccine Confidence in the United States

April 5, 2022
Northwestern University Researchers Develop Nanoparticle Vaccine Platform
Medical Countermeasures

Northwestern University Researchers Develop Nanoparticle Vaccine Platform

March 22, 2022
Load More

Latest News

NIH to Further Invest in Point-of-Care Technologies Research Network

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022

How a COVID-19 Infection Spurs Antibodies Against Common Colds

May 8, 2022
Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

Hospitals Resilience to Extreme Events: One-Third of Staff May Be Lost During a Disaster

May 6, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC